Results 61 to 70 of about 146,617 (291)

Vaccination Uptake and Patient Perceptions Among Haemodialysis Patients: Insights From a Cross‐Sectional Study

open access: yesJournal of Renal Care, Volume 51, Issue 4, December 2025.
ABSTRACT Background Haemodialysis patients face an elevated risk of infectious diseases due to immunosuppression and frequent exposure to healthcare settings. Vaccination is a critical preventive strategy for this population; however, coverage remains inconsistent across different vaccines.
Eirini Potamianou   +6 more
wiley   +1 more source

Māori and community news constructions of Meningococcal B: the promotion of a moral obligation to vaccinate [PDF]

open access: yes, 2007
News media communicate various risks of disease, showcase medical breakthroughs and disseminate texts that both reflect and renegotiate shared cultural understandings of health and illness. Little is known about the role of Māori and community news media
Chamberlain, Kerry   +5 more
core   +2 more sources

Risk factors for acquisition of meningococcal carriage in the African meningitis belt

open access: yesTropical medicine & international health, 2019
To investigate potential risk factors for acquisition in seven countries of the meningitis belt.
L. Cooper   +80 more
semanticscholar   +1 more source

Narsoplimab Results in Excellent Survival in Adults and Children With Hematopoietic Cell Transplant Associated Thrombotic Microangiopathy (TA‐TMA)

open access: yesAmerican Journal of Hematology, Volume 100, Issue 11, Page 2040-2051, November 2025.
ABSTRACT Inappropriate complement activation is a key driver of hematopoietic cell transplant‐associated thrombotic microangiopathy (TA‐TMA). Treatment with narsoplimab, an inhibitor of MASP‐2, the effector enzyme of the lectin pathway, resulted in a response rate of 61% in a Phase 2 clinical trial in adults with TA‐TMA.
Michelle L. Schoettler   +6 more
wiley   +1 more source

The cost-effectiveness of alternative vaccination strategies for polyvalent meningococcal vaccines in Burkina Faso: A transmission dynamic modeling study. [PDF]

open access: yes, 2018
BACKGROUND: The introduction of a conjugate vaccine for serogroup A Neisseria meningitidis has dramatically reduced disease in the African meningitis belt.
Cohen, Ted   +8 more
core   +3 more sources

The Silent Risk of Sudan Virus: A Review Addressing Global Health Vulnerabilities

open access: yesHealth Science Reports, Volume 8, Issue 11, November 2025.
ABSTRACT Background and Aim Sudan Virus Disease (SVD) is a deadly hemorrhagic fever caused by the Sudan virus, first discovered in Sudan in 1976. This disease has been linked to several outbreaks in sub‐Saharan Africa, particularly in Uganda. The high fatality rate of SVD, ranging from 41% to 70%, emphasizes the critical need for effective preventive ...
Syed Masudur Rahman Dewan   +1 more
wiley   +1 more source

Adjuvants : an essential component of neisseria vaccines [PDF]

open access: yes, 2009
Adjuvants may be classified into delivery systems and immune potentiator or modulator molecules based on their mechanism of action. Neisseria vaccines containing traditional adjuvants such as aluminium salts have existed for long time, but meningitis ...
Acevedo, R.   +8 more
core  

From the microbiome to the central nervous system, an update on the epidemiology and pathogenesis of bacterial meningitis in childhood [version 1; referees: 3 approved] [PDF]

open access: yes, 2017
In the past century, advances in antibiotics and vaccination have dramatically altered the incidence and clinical outcomes of bacterial meningitis. We review the shifting epidemiology of meningitis in children, including after the implementation of ...
Janowski, Andrew B, Newland, Jason G
core   +3 more sources

Successful African introduction of a new Group A meningococcal conjugate vaccine: Future challenges and next steps

open access: yesHuman Vaccines & Immunotherapeutics, 2018
The introduction of a new Group A meningococcal conjugate vaccine, MenAfriVacR, has been a important public health success. Group A meningococcal meningitis has disappeared in all countries where the new Men A conjugate vaccine has been used at public ...
F. Marc LaForce   +3 more
doaj   +1 more source

Meningococcal Meningitis Surveillance in the African Meningitis Belt, 2004–2013

open access: yesClinical Infectious Diseases, 2015
Background. An enhanced meningitis surveillance network was established across the meningitis belt of sub-Saharan Africa in 2003 to rapidly collect, disseminate, and use district weekly data on meningitis incidence.
C. Lingani   +7 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy